Real-Life Comparative Effectiveness of IL-23 Inhibitors in the Treatment of Moderate to Severe Psoriasis: A Multicenter Experience. Dermatol Pract Concept 2024, 14 (3), e2024179. https://doi.org/10.5826/dpc.1403a179.